DNMRQ — Danimer Scientific Share Price
- $1.18m
- $366.89m
- $46.68m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.01 | ||
Price to Tang. Book | 0.01 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.03 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -12.99% | ||
Return on Equity | -43.11% | ||
Operating Margin | -216.11% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | 47.33 | 58.75 | 53.22 | 46.68 | 46 | 99 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Danimer Scientific, Inc. is a performance polymer company. The Company specializes in bioplastic replacements for traditional petroleum-based plastics. Its technologies include Polyhydroxyalkanoate (PHA)-based Resins, Polylactic acid (PLA)-based Resins and Rinnovo. It harvests the PHA from the bacteria, then purifies and filters the bioplastic before forming the non-formulated PHA into pellets. Its PHA is a naturally occurring bioplastic that effectively biodegrades in both anaerobic environments, such as a waste treatment facility, and aerobic environments. It sells the PHA under its proprietary Nodax brand name. PLA is made from dextrose derived from corn, sugar beets and sugar cane, among other sources. Applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. The Company primarily markets its products to consumer packaging brand owners, converters and manufacturers in the plastics industry.
Directors
- Stephen Croskrey CHM (61)
- John Dowdy CFO
- Michael Smith COO (52)
- Phillip Van Trump CTO (44)
- Scott Tuten CMO (45)
- Stuart Pratt DRC (75)
- John Amboian IND (60)
- Christy Basco IND (54)
- Philip Calhoun IND (58)
- Richard Hendrix IND (55)
- Gregory Hunt IND (64)
- Isao Noda IND (70)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- May 24th, 2019
- Public Since
- May 6th, 2020
- No. of Shareholders
- 359
- No. of Employees
- 257
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 3,019,887

- Address
- 140 Industrial Boulevard, BAINBRIDGE, 39817
- Web
- https://www.liveoakacq.com/
- Phone
- +1 9016852865
- Auditors
- KPMG LLP
Upcoming Events for DNMRQ
Danimer Scientific Inc Annual Shareholders Meeting
Q2 2025 Danimer Scientific Inc Earnings Release
Similar to DNMRQ
Advanced Container Technologies
Pink Sheets on Nasdaq
Alkane
Pink Sheets on Nasdaq
Angstrom Technologies
Pink Sheets on Nasdaq
Asia Carbon Industries
Pink Sheets on Nasdaq
BioLargo
Pink Sheets on Nasdaq
FAQ
As of Today at 20:10 UTC, shares in Danimer Scientific are trading at $0.39. This share price information is delayed by 15 minutes.
Shares in Danimer Scientific last closed at $0.39 and the price had moved by -98.8% over the past 365 days. In terms of relative price strength the Danimer Scientific share price has underperformed the S&P500 Index by -98.88% over the past year.
The overall consensus recommendation for Danimer Scientific is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreDanimer Scientific does not currently pay a dividend.
Danimer Scientific does not currently pay a dividend.
Danimer Scientific does not currently pay a dividend.
To buy shares in Danimer Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.39, shares in Danimer Scientific had a market capitalisation of $1.18m.
Here are the trading details for Danimer Scientific:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: DNMRQ
Based on an overall assessment of its quality, value and momentum Danimer Scientific is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Danimer Scientific is $4.50. That is 1053.85% above the last closing price of $0.39.
Analysts covering Danimer Scientific currently have a consensus Earnings Per Share (EPS) forecast of -$30.10 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Danimer Scientific. Over the past six months, its share price has underperformed the S&P500 Index by -97.44%.
As of the last closing price of $0.39, shares in Danimer Scientific were trading -95.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Danimer Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.39.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Danimer Scientific's management team is headed by:
- Stephen Croskrey - CHM
- John Dowdy - CFO
- Michael Smith - COO
- Phillip Van Trump - CTO
- Scott Tuten - CMO
- Stuart Pratt - DRC
- John Amboian - IND
- Christy Basco - IND
- Philip Calhoun - IND
- Richard Hendrix - IND
- Gregory Hunt - IND
- Isao Noda - IND